Details for New Drug Application (NDA): 217227
✉ Email this page to a colleague
The generic ingredient in TETRACAINE HYDROCHLORIDE is tetracaine hydrochloride. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the tetracaine hydrochloride profile page.
Summary for 217227
| Tradename: | TETRACAINE HYDROCHLORIDE |
| Applicant: | Somerset Theraps Llc |
| Ingredient: | tetracaine hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 217227
| Physiological Effect | Local Anesthesia |
Medical Subject Heading (MeSH) Categories for 217227
Suppliers and Packaging for NDA: 217227
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TETRACAINE HYDROCHLORIDE | tetracaine hydrochloride | SOLUTION;OPHTHALMIC | 217227 | ANDA | Somerset Therapeutics, LLC | 70069-596 | 70069-596-01 | 1 BOTTLE in 1 CARTON (70069-596-01) / 5 mL in 1 BOTTLE |
| TETRACAINE HYDROCHLORIDE | tetracaine hydrochloride | SOLUTION;OPHTHALMIC | 217227 | ANDA | Somerset Therapeutics, LLC | 70069-597 | 70069-597-01 | 1 BOTTLE in 1 CARTON (70069-597-01) / 15 mL in 1 BOTTLE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;OPHTHALMIC | Strength | 0.5% | ||||
| Approval Date: | Dec 20, 2024 | TE: | AB1 | RLD: | No | ||||
| Regulatory Exclusivity Expiration: | Jun 25, 2025 | ||||||||
| Regulatory Exclusivity Use: | COMPETITIVE GENERIC THERAPY | ||||||||
Complete Access Available with Subscription
